A systematic review of cost-effectiveness analyses of complex wound interventions reveals optimal treatments for specific wound types

Table 8 Cost-effectiveness analysis (CEA) outcomes for venous and venous/arterial ulcers (n = 2)

CEA (Original year of values)	Treatment vs. Comparator	ICER summary/estimate [2013 US$]	Unit of effectiveness	Incremental cost [2013 US$]	Incremental effectiveness
Dumville 2009 (2006) [46]	larval therapy vs. hydrogel	17,757^a	QALY gained	195	0.011
Ohlsson 1994 (1993) [47]	hydrocolloid (DuoDERM) dressing vs. saline gauze	Dominant^a	Additional wound healed	−588	0.357

ICER, Incremental cost-effectiveness ratio; QALY, Quality-adjusted life-year; US$, United States dollars.
^aDenotes the higher quality studies (Drummond score ≥8).

ISSN: 1741-7015